Phase 4 N=27 A Randomised Cross-over Study With Two 1-piece Urostomy Bags.
Urostomy
Primary: Preference of Sensura vs Moderma — 45; 43 percentage of prefering the product
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
Phase 3 N=30 Comparison of Two Urostomy Bags (2-piece).
Urostomy Patent
Primary: Preference of the Two Urostomy Products — 21; 4 participants
N/A N=49 Patient-operated Valved Catheter Versus Indwelling Transurethral Catheter
Bladder Dysfunction · Urinary Retention
Primary: Total Catheter Related Pain — 1.25; 2.3 units on a scale
N/A N=25 Investigation of a Supporting Ostomy Product Intended for Leakage Detection
Stoma Ileostomy
Primary: System Performance Accuracy of Pictures — 122; 126; 24; 45 Pictures
Phase 4 N=130 Evaluation of Ureteral Patency in the Post-indigo Carmine Era
Ureteral Patency
Primary: Visual Analog Scale (VAS) — 48; 20; 0; 28 score on a scale
N/A N=24 Drainage of Malignant Extrinsic Ureteral Obstruction Using the Memokath Ureteral Stent
Ureteral Obstruction
Primary: Mean Stent Dwell Time — 17; 3.97 months
N/A N=20 A Clinical Investigation of New Ostomy Appliances
Leakage
Primary: Leakage Under the Base Plate Using a 24-point Scale — 4.5; 3.3; 4.4 units on a scale
N/A N=41 B3 Buddy for Securing Urinary Drainage Bag to Patient While Walking
Urinary System Disorder
Primary: Acceptability of Device — 100 percentage of participants
N/A N=28 A Clinical Investigation Examining the Performance and Handling of New 2-piece Ostomy Products in 28 People With an Ileostomy.
Ileostomy - Stoma
Primary: Degree of Leakage — 6.4; 3.4; 7.0; 7.0 units on a scale
N/A N=127 Investigation of Newly Developed Ostomy Products in Subjects With Ileostomy
Stoma Ileostomy
Primary: Degree of Leakage — 5.1; 5.8 units on a scale
Phase 4 N=122 Performance Study of Newly Developed Ostomy Products
Stoma Colostomy
Primary: Degree of Leakage. Each Baseplate Can Have a Score From 0-24 Points Were 0 is the Best Possible Outcome (No Leakage) and 24 Points is the Worst Possible Outcome (Full…
N/A N=64 Safety and Performance of New 1-piece Ostomy Product
Stoma Ileostomy
Primary: Degree of Leakage — 50; 44; 41; 60 percentage of baseplates with no leakage
N/A N=22 Investigation of the Performance and Safety of New 1-piece Open Ostomy Appliances Compared to Standard Care
Ileostomy - Stoma
Primary: Degree of Leakage — 4; 4.6; 2.6 units on a scale
N/A N=25 An Investigation of Ostomy Devices
Ileostomy
Primary: Degree of Leakage — 4.2; 4.3; 4.4; 4.3 units on a scale
N/A N=55 Investigation of Two New 1-piece Ostomy Products in People With an Ileostomy or Colostomy
Ileostomy · Colostomy
Primary: Fit to Body — 93; 88; 57 percentage of good or very good
N/A N=24 The RELIEF™ Ureteral Stent - Assessment of Retrograde Urinary Reflux and Distal Coil Bladder Position
Ureteral Obstruction
Primary: Incidence of Bladder Irritation Symptoms (e.g. Frequency, Urgency, Nocturia, Urine Leakage...) Associated With the RELIEF Stent. — 51.95 Units on a scale
N/A N=84 Treatment for Acute Postoperative Voiding Dysfunction
Urinary Retention
Primary: Persistent Retention — 29; 21 participants
N/A N=107 Use of The Spanner Temporary Prostatic Stent as an Alternative to a Urinary Catheter to Achieve Bladder Drainage in Men
Urinary Retention
Primary: Number of Participants Who Achieved Post-void Residual (PVR) of ≤150 ml Over 90 Days — 79 Participants
N/A N=158 Self-discontinuation of a Transurethral Catheter
Postoperative Urinary Retention
Primary: Number of Participants With Postoperative Urinary Retention — 11; 11 Participants — p=0.5
Phase 3 N=121 3,3'-Dioxo-2,2'-Bisindolylidene-5,5'-Disulfonate Disodium 0.8% Solution as an Aid for Ureteral Patency
Ureter Injury
Primary: Urine Jet Conspicuity Score — 4.1; 4.2; 2.5 score on a scale — p=<0.0001
N/A N=74 A Clinical Investigation Evaluating and Understanding Parameters Affecting the Performance of Ostomy Products
Ileostomy - Stoma · Colostomy
Primary: Leakage Under the Baseplate (cm^2) — 9.2; 6.6 cm2
N/A N=81 Clinical Trial of New Intermittent Single-use Catheter
Urinary Incontinence
Primary: Residual Volume at 1st Flow-stop (Catheterisation Performed by HCP) — 23.22; 15.87 milliliters
N/A N=216 Ostomy Telehealth For Cancer Survivors
Colostomy Stoma
Primary: Patient Activation Measure (PAM), a 100 Point Scale Determining Patient Engagement in Healthcare. — 66.9; 64.2; 67.6; 66.2 score on a scale — p=0.06
N/A N=38 Investigation of a New 1-piece Convex Ostomy Product
Stoma Ileostomy · Stoma Colostomy
Primary: Degree of Leakage — 2.6; 4.8; 2.5 units on a scale
N/A N=18 Investigation of Newly Developed 1-piece Convex Baseplates in Subjects With Ileostomy
Ileostomy - Stoma
Primary: Degree of Leakage — 1.9; 2.5; 3.1 units on a scale
N/A N=16 Feasibility Study Evaluating the ParaPatch System
Urinary Incontinence
Primary: Number of Participants Who Used the ParaPatch System With Adverse Events Through the Completion of the Study — 8; 6 participants
N/A N=47 Clinical Investigation of an Improved Two-piece Stoma Product for People Living With a Stoma
Surgical Stomas
Primary: Leakage Through Coupling Registered at Each Bag Change (Yes/no) — 0.151; 0.237 Proportion of bag changes/participant — p=0.164
N/A N=20 Evaluation of a Novel Electronic Urine Output Monitor (eUOM)
Oliguria · Polyuria
Primary: Urine Output of SOC Device Versus Accuryn — 0; 5 Patients with airlocks
Phase 3 N=71 The OLYMPUS Study - Optimized DeLivery of Mitomycin for Primary UTUC Study
Carcinoma, Transitional Cell · Transitional Cell Carcinoma of Renal Pelvis
Primary: The Primary Efficacy Endpoint Was the Number of Patients Attaining Complete Response (CR) at the End of the Treatment Period (PDE Visit). — 42 Participants
N/A N=107 Phenazopyridine for Confirmation of Ureteral Patency
Cystoscopy
Primary: Time to Visualize Ureteral Urine Flow Intraoperatively Measured by Timing in the Operating Room — 160; 173 seconds — p=0.77